Related references
Note: Only part of the references are listed.Multifunctional Biomedical Materials Derived from Biological Membranes
Yuemin Wang et al.
ADVANCED MATERIALS (2022)
Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment
Akhil Srivastava et al.
SEMINARS IN CANCER BIOLOGY (2022)
Recent advances and prospects in gemcitabine drug delivery systems
Shweta Paroha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah Blythe Doroshow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Paradigms on Immunotherapy Combinations with Chemotherapy
Diego Salas-Benito et al.
CANCER DISCOVERY (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
D. Miles et al.
ANNALS OF ONCOLOGY (2021)
Passive targeting of high-grade gliomas via the EPR effect: a closed path for metallic nanoparticles?
Carlos Caro et al.
BIOMATERIALS SCIENCE (2021)
PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation
Min Yang et al.
BIOMATERIALS SCIENCE (2021)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
The Role of Exosomes in the Female Reproductive System and Breast Cancers
Yuqi Bai et al.
ONCOTARGETS AND THERAPY (2020)
Targeting DNA Damage Response in Prostate and Breast Cancer
Antje M. Wengner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial
Amelie de Gregorio et al.
BREAST CANCER RESEARCH (2020)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Nathan D. Donahue et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
Constantia Pantelidou et al.
CANCER DISCOVERY (2019)
CSF1R-and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages
Anujan Ramesh et al.
ADVANCED MATERIALS (2019)
PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
Xudong Zhang et al.
ADVANCED MATERIALS (2018)
Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells
Jinhui Zhu et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2018)
Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide-Generating Agents Improves the Therapeutic Effects of Nanomedicines
Waliul Islam et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Engineering PD-1-Presenting Platelets for Cancer Immunotherapy
Xudong Zhang et al.
NANO LETTERS (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns
Mina Nikanjam et al.
ONCOIMMUNOLOGY (2017)
Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles
Jingwei Ma et al.
CELL RESEARCH (2016)
Regulation of chronic inflammatory and immune processes by extracellular vesicles
Paul D. Robbins et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
Naiyer A. Rizvi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer
Xiaohong Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
The Role of Exosomes in Breast Cancer
Michelle C. Lowry et al.
CLINICAL CHEMISTRY (2015)
Cell or Cell Membrane-Based Drug Delivery Systems
Songwei Tan et al.
THERANOSTICS (2015)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Share Paper
